Skip to main content

Farringdon Capital, Ltd.

Position in BSX — Boston Scientific Corp

CIK 1750980 LONDON, X0

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,391,026
+$187,517 QoQ
Shares Held
38,104
+68.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Farringdon Capital, Ltd. holds $650,247 across 1 Medical Devices name.

# Ticker Company Shares Value (USD) Open

All Filings in BSX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,391,026 38,104
2025-09-30 $2,203,509 22,570
2025-03-31 $210,435 2,086